Supplementary Figure 1 from <i>FGFR1</i> Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas
Jorge S. Reis‐Filho(AstraZeneca (France)), Alan Ashworth(University of California, San Francisco), David Sarrió(Instituto de Investigaciones Biomédicas Sols-Morreale), Sunil R. Lakhani(Sullivan Nicolaides Pathology), Anita Grigoriadis(London Cancer), Marjan Iravani(Institute of Cancer Research), Nicholas C. Turner(Institute of Cancer Research), David Hardisson(Universidad Autónoma de Madrid), Alan Mackay(Institute of Cancer Research), Pete T. Simpson, Kay Savage(Institute of Cancer Research), Kerry Fenwick(Institute of Cancer Research), Fernando Schmitt(Universidade do Porto), Maryou Ballo Lambros(Institute of Cancer Research), Tim Dexter(Institute of Cancer Research), Barbara L. Weber, José Palacios(Universidad de Alcalá), Chris Jones(North Carolina State University)
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k